Assignee
ARISAN THERAPEUTICS INC
US·4 granted patents·3 pending applications·2 citations·filing 2017–2023
Top patents by PatentIndex Score
7 records- 0176US11352328B2Heterocyclic compounds for the treatment of arenavirusARISAN THERAPEUTICS INC·Filed 2017·Granted Jun 7, 2022·2 cites·29 claims
- 0264US2022281825A1Heterocyclic compounds for the treatment of arenavirus infectionARISAN THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0358US2023303569A1Heterocyclic compounds as therapeutic agentsARISAN THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0451US12419865B2Compounds for the treatment of arenavirus infectionARISAN THERAPEUTICS INC·Filed 2019·Granted Sep 23, 2025·0 cites·19 claims
- 0550US2024238265A1Adamantane amides and thioamides for the treatment of ebolavirus infectionARISAN THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0644US12240857B2Adamantane derivatives for the treatment of filovirus infectionARISAN THERAPEUTICS INC·Filed 2018·Granted Mar 4, 2025·0 cites·20 claims
- 0737US11548893B2Enantiomerically pure adamantane carboxamides for the treatment of filovirus infectionARISAN THERAPEUTICS INC·Filed 2018·Granted Jan 10, 2023·0 cites·52 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →